ArticleBone marrow transplantation2008
Significance of low peripheral blood CD34+ cell numbers prior to leukapheresis: what should the threshold required for apheresis be?
Article in Bone marrow transplantation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Intra-apheresis CD34+ cell count: A dynamic approach to predicting peripheral blood stem cell collection yield.Transfusion · 2026Article
- Population Pharmacokinetic-Pharmacodynamic Modeling of Granulocyte Colony-Stimulating Factor to Optimize Dosing and Timing for CD34Clinical and translational science · 2025Article
- Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma.Bone marrow transplantation · 2010Article
- Multiple myeloma patients receiving large volume leukapheresis efficiently yield enough CD34+ cells to allow double transplants.Journal of clinical apheresis · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pre-apheresis peripheral blood CD34+ cell count (PBCD34) is the strongest predictor of the number of stem cells collected. It is common practice to apherese only when PBCD34 is >or=5/microl to avoid poor yields. However, in patients with compromised marrow function, the only way to get enough cells is to collect small numbers daily several times. Another pitfall with this practice is not accounting for weight. We studied 285 autologous collections performed with PBCD34 <5/microl. The blood volume processed was 15 l (n=68) or 20 l (n=217). A collection of >or=0.3 x 10(6) CD34+ cells per kg ideal body weight (IBW) was considered acceptable as this daily yield over a week could total >or=2 x 10(6)/kg-enough for an autograft. Two hundred and four harvests (72%) had yields of >or=0.3; with 59% being >or=0.4, 47% being >or=0.5 and 36% being >or=0.6. There were 23 patients whose harvests done when PBCD34 was low totaled >or=2 x 10(6)/kg. Assuming a 20-l apheresis with 70% collection efficiency, we suggest harvesting if 14 n/w >or=0.3, where n=PBCD34 and w=IBW. This approach is more logical than using an absolute threshold, and will ensure that patients are not deprived of the opportunity of stem cell collection and autotransplantation.
Indexed as
Identifiers
18604244What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.